Archives
-
MOG (35-55) for EAE and MS Research
2026-09-30
MOG (35-55) provides a reproducible antigen-driven route to model demyelinating neuroinflammation and connect clinical disease scores with immune and molecular readouts. This workflow also enables pathway-focused testing of STAT1/STAT2 and PARP7 biology highlighted in recent experimental autoimmune encephalomyelitis research.
-
Cy5.5 NHS Ester for NIR Nanoparticle Tracking
2026-09-30
Build a practical near-infrared labeling workflow for proteins, peptides, oligonucleotides, and amine-functionalized nanoparticles. This guide translates a recent MOF nanoparticle epilepsy study into fluorescence-based biodistribution, brain-delivery, and assay-validation strategies while addressing solubility, hydrolysis, purification, and signal interpretation.
-
Cy5 Maleimide and the Charge Logic of Condensates
2026-09-29
Biomolecular condensates are not passive containers: their electrostatic environment can determine which labeled proteins and probes enter, leave, or accumulate. This thought-leadership guide connects the charge-dependent behavior of α-synuclein condensates with practical protein-labeling strategy using non-sulfonated Cy5 maleimide.
-
ASB3 E3 Ligase Targets MAVS in Antiviral Immunity
2026-09-29
The 2024 Cell Death & Differentiation study identifies ASB3 as an inducible E3 ubiquitin ligase that weakens RNA-virus sensing by targeting MAVS for K48-linked, proteasome-dependent degradation. Genetic, biochemical, infection, and animal data connect ASB3 to reduced TBK1–IRF3 activation, impaired type I interferon production, and increased influenza susceptibility.
-
OPP Protein Synthesis Assay: B-Cell Workflow
2026-09-28
O-propargyl-puromycin (OPP) converts a brief translation pulse into a quantitative readout of global protein synthesis in B cells and other models. This practical guide connects click-chemistry labeling with mitochondrial stress experiments, flow cytometry, imaging, and proteomics-oriented workflows.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-09-28
This study develops a localized strategy for restoring the tumor suppressor p21: chemically modified p21 mRNA is packaged in lipid nanoparticles and delivered into the bladder. The reported cell and mouse-model findings support further investigation of intravesical mRNA delivery, while leaving dose, durability, and clinical benefit to be established.
-
Angiotensin III: From RAAS Biology to Translational Tests
2026-09-27
Angiotensin III connects classic renin–angiotensin–aldosterone system biology with emerging evidence on angiotensin peptides and SARS-CoV-2 spike-receptor binding. This article outlines how translational teams can test that connection without overstating what early binding assays demonstrate.
-
Sulfo-Cy5 Carboxylic Acid for Assay Tracking
2026-09-26
Use Sulfo-Cy5 carboxylic acid to build aqueous fluorescence workflows for monitoring labeled proteins and peptides, while keeping the distinction between a fluorescent tracer and a vaccine adjuvant clear. Practical activation, imaging, and troubleshooting guidance connects the dye’s far-red signal to PLGA nano-adjuvant experiments without implying that the reference study used this product.
-
Bismuth Subsalicylate in GI Research Workflows
2026-09-25
Build a careful gastrointestinal research workflow around Bismuth Subsalicylate while accounting for its poor solubility and the difference between nominal dose and dissolved exposure. Pair pathway-oriented measurements with orthogonal viability and membrane assays to distinguish inflammation-related signals from general cell injury.
-
Spleen-Targeted mRNA Vaccine Builds HCC Immunity
2026-09-25
Lin and colleagues report that a spleen-targeted neoantigen mRNA vaccine elicited antitumor activity in an orthotopic hepatocellular carcinoma model and identified ISG15-positive CD8-positive T cells as key effectors. Their findings connect GZMA–F2R-mediated immune-cell interactions with tertiary lymphoid structure formation, while highlighting that delivery, antigen design, and RNA engineering are distinct parts of vaccine development.
-
Transfection Strategy: From Complexes to Translation
2026-09-24
Transfection success depends on more than reagent choice: DNA concentration, reaction volume, cell state, and scale all shape delivery and expression. This article connects calcium-phosphate optimization findings with the mechanism and practical role of Polyethylenimine Linear (PEI), MW 40,000, helping translational teams choose and validate workflows without treating one protocol as universal.
-
EZ Cap Cy5 Firefly Luciferase mRNA for Delivery
2026-09-24
Track mRNA uptake and reporter expression in complementary fluorescence and bioluminescence readouts. This workflow pairs the dual-reporter design of EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) with practical delivery optimization—and puts emerging MOF carriers in context without assuming they are interchangeable with lipid reagents.
-
From Nanoadjuvant Biology to Mucosal Imaging
2026-09-23
A PLGA-based vaccine-adjuvant study shows why translational imaging must connect particle localization to immune outcomes. This article outlines how Sulfo-Cy5 carboxylic acid can support that investigation—and where tracer design and controls are essential.
-
5-Aminolevulinic acid HCl for Heme Assays
2026-09-23
Use 5-Aminolevulinic acid HCl as a controlled pathway-entry perturbation—not simply as a heme supplement—to connect heme flux with bacterial immune evasion, macrophage phenotypes, and porphyrin-based cancer research. This guide combines assay design, practical dosing considerations, and troubleshooting for reproducible workflows.
-
Dual-Mode mRNA Delivery: From Uptake to Function
2026-09-22
Successful mRNA delivery is not defined by cellular entry alone; it depends on intracellular processing, release, and translation. This thought-leadership article connects the mechanistic findings on LNP surface charge and target-cell V-ATPase activity with a dual-reporter workflow using EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) to separate physical delivery from functional expression.